| Multivalent and multispecific DR5-binding fusion proteins |
2022-12-21 |
2023-2-02 |
|
| Multivalent and multispecific ox40-binding fusion proteins |
2022-11-29 |
2023-1-01 |
|
| Nkp46-binding polypeptides and uses thereof |
2022-8-29 |
2023-3-09 |
|
| Nkp46-targeted modified il-2 polypeptides and uses thereof |
2022-8-29 |
2023-3-09 |
|
| CD123-Binding Polypeptides and Uses Thereof |
2022-8-01 |
2023-3-02 |
|
| Cd8-targeted modified il-2 polypeptides and uses thereof |
2022-7-19 |
2023-1-26 |
|
| Cd28 single domain antibodies and multivalent and multispecific constructs … |
2022-7-19 |
2022-9-01 |
|
| Cd8-binding polypeptides and uses thereof |
2022-7-19 |
2023-1-26 |
|
| Formulations of dr5 binding polypeptides |
2022-2-18 |
2022-8-25 |
|
| Aqueous solution compositions for increasing stability of engineered dimeric … |
2022-2-17 |
2022-8-25 |
|
| Multivalent and multispecific 41BB-binding fusion proteins |
2022-2-11 |
2022-3-03 |
|
| Pd-1 single domain antibodies and therapeutic compositions thereof |
2021-11-11 |
2022-5-26 |
|
| Aml targeted immunotherapies |
2021-11-09 |
2022-5-12 |
|
| Cd33 targeted immunotherapies |
2021-11-09 |
2022-5-12 |
|
| Clec12a-binding polypeptides and uses thereof |
2021-11-01 |
2022-1-01 |
|
| Cll-1 targeted immunotherapies |
2021-11-01 |
2022-1-01 |
|
| Cd33-binding polypeptides and uses thereof |
2021-11-01 |
2022-1-01 |
|
| Cd33 targeted immunotherapies |
2021-11-01 |
2022-1-01 |
|
| Serpin fusion polypeptides and methods of use thereof |
2021-9-28 |
2021-10-28 |
|
| Polypeptides Comprising Il-2 Modified Polypeptides and Uses Thereof |
2021-7-05 |
2022-3-04 |
|
| Polypeptides comprising modified il-2 polypeptides and uses thereof |
2021-7-01 |
2022-1-06 |
|
| Serpin fusion polypeptides and methods of use thereof |
2021-5-10 |
2022-10-13 |
|
| Canine PD-1 Binding Polypeptides and Uses Thereof |
2021-5-03 |
2023-1-10 |
|
| Non-immunogenic single domain antibodies |
2021-4-16 |
2021-5-13 |
|
| Serpin fusion polypeptides and methods of use thereof |
2021-4-07 |
2021-5-06 |
|
| Ox40-binding polypeptides and uses thereof |
2021-2-11 |
2021-4-29 |
|
| Non-platelet depleting and non-red blood cell depleting cd47 antibodies and … |
2021-2-08 |
2021-10-14 |
|
| Multispecific polypeptide constructs having constrained cd3 binding and related … |
2020-10-07 |
2020-11-30 |
|
| Non-platelet depleting and non-red blood cell depleting cd47 antibodies and … |
2020-5-10 |
2020-6-30 |
|
| IMMUNOTHERAPIES TARGETING CD123 |
2020-5-07 |
2022-3-16 |
|
| Dll3 single domain antibodies and therapeutic compositions thereof |
2019-10-09 |
2020-4-16 |
|
| 5t4 single domain antibodies and therapeutic compositions thereof |
2019-10-09 |
2020-6-16 |
|
| B7h3 single domain antibodies and therapeutic compositions thereof |
2019-10-09 |
2020-4-16 |
|
| Multispecific polypeptide constructs having constrained cd3 binding and methods … |
2019-10-07 |
2020-9-28 |
|
| Multispecific polypeptide constructs containing a constrained cd3 binding … |
2019-7-23 |
2021-6-02 |
|
| Type III Secretion System Targeting Molecules |
2019-5-22 |
2019-11-14 |
|
| Multivalent and multispecific gitr-binding fusion proteins |
2018-8-31 |
2019-4-04 |
|
| Wap domain fusion polypeptides and methods of use thereof |
2015-2-06 |
2015-5-28 |
|
| Serpin fusion polypeptides and methods of use thereof |
2012-6-28 |
2021-12-24 |
|
| Serpin fusion polypeptides and methods of use thereof |
2012-6-28 |
2015-11-03 |
|
| Serpin fusion polypeptides and methods of use thereof |
2012-6-28 |
2022-3-25 |
|